OTCMKTS:GBLX GB Sciences (GBLX) Stock Price, News & Analysis → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free GBLX Stock Alerts $0.0068 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$0.0065▼$0.006950-Day Range$0.0052▼$0.007852-Week Range$0.01▼$0.02Volume23,304 shsAverage Volume125,282 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get GB Sciences alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About GB Sciences Stock (OTCMKTS:GBLX)GB Sciences, Inc., a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.Read More GBLX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GBLX Stock News HeadlinesMarch 12, 2024 | bbc.comGB News posts £42m loss but grows online audienceDecember 14, 2023 | finance.yahoo.comGb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)April 23, 2024 | DTI (Ad)Here’s how to start a “Weekend Side Hustle” from your sofaHere’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.November 2, 2023 | dailymail.co.ukTeam GB News: Medals and Schedule at Winter OlympicsOctober 8, 2023 | mirror.co.ukDan Wootton's replacement on GB News revealed as he's suspended over Laurence Fox rantOctober 6, 2023 | mirror.co.ukGB News boss explains why Dan Wootton is still on air amid allegations against presenterOctober 3, 2023 | mirror.co.ukGB News suspends third presenter for supporting Dan Wootton in Laurence Fox rowOctober 2, 2023 | dailymail.co.ukGB News - Updates on the British television news channelApril 23, 2024 | Whats On Finance (Ad)Putin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. July 11, 2023 | finance.yahoo.comGb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of LethbridgeJune 20, 2023 | reuters.comINSIGHT-Lab crunch: British science has nowhere to goMay 27, 2023 | finance.yahoo.comGBLX - GB Sciences, Inc.March 20, 2023 | finance.yahoo.comGB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in ChinaMarch 7, 2023 | finance.yahoo.comSuccessful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery PlatformFebruary 18, 2023 | benzinga.comGB Sciences Stock (OTC:GBLX), Quotes and News SummaryDecember 26, 2022 | benzinga.comGb Sciences Identifies Novel Cannabis-Inspired Mixtures That Could Treat Viral InfectionsDecember 12, 2022 | finance.yahoo.comGb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based FormulationsNovember 1, 2022 | msn.comCannabis Terpenes Reduce Inflammation, Says Gb Sciences StudyNovember 1, 2022 | finance.yahoo.comGb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis IngredientsOctober 27, 2022 | finance.yahoo.comTODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic SummitOctober 24, 2022 | finance.yahoo.comGb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal StudyOctober 13, 2022 | finance.yahoo.comTODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 ConferenceOctober 10, 2022 | msn.comNew Study Shows Promising Results In Treatment Of Parkinson's Disease With CannabinoidsOctober 10, 2022 | finance.yahoo.comGb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's DiseaseSeptember 6, 2022 | finance.yahoo.comTODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal ArticleAugust 9, 2022 | ca.finance.yahoo.comGB Sciences, Inc. (GBLX)July 20, 2022 | stockhouse.comGb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform-PhAROS(TM)See More Headlines Receive GBLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2016Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolOTCMKTS:GBLX CUSIPN/A CIK1165320 Webgbsciences.com Phone(866) 721-0297FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. John Claybron Poss (Age 76)CEO, Interim CFO & Chairman Comp: $60kDr. Andrea Small-Howard M.B.A. (Age 55)MBA, Ph.D., Chairman of Scientific Advisory Board, Chief Science Officer, President & Director Comp: $138kMr. Gary R. Henrie Esq. (Age 70)Securities Counsel & Company Secretary Key CompetitorsCNBX PharmaceuticalsOTCMKTS:CNBX180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All Competitors GBLX Stock Analysis - Frequently Asked Questions How have GBLX shares performed in 2024? GB Sciences' stock was trading at $0.0064 on January 1st, 2024. Since then, GBLX shares have increased by 6.9% and is now trading at $0.0068. View the best growth stocks for 2024 here. Are investors shorting GB Sciences? GB Sciences saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 1,000 shares, a decrease of 66.7% from the March 15th total of 3,000 shares. Based on an average daily volume of 178,800 shares, the short-interest ratio is currently 0.0 days. View GB Sciences' Short Interest. How were GB Sciences' earnings last quarter? GB Sciences, Inc. (OTCMKTS:GBLX) released its quarterly earnings data on Monday, November, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter. What other stocks do shareholders of GB Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other GB Sciences investors own include KushCo (KSHB), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MassRoots (MSRT), Surna (SRNA), Gran Tierra Energy (GTE), GreenGro Technologies (GRNH), MariMed (MRMD), Pennsylvania Real Estate Investment Trust (PEI) and Diamond Wellness (POTN). How do I buy shares of GB Sciences? Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:GBLX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GB Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
